✦ LIBER ✦

Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial

✍ Scribed by S. Pol; R. H. Ghalib; V. K. Rustgi; C. Martorell; G. T. Everson; H. A. Tatum; C. Hézode; J. K. Lim; J. Bronowicki; G. A. Abrams; N. Bräu; D. W. Morris; P. J. Thuluvath; R. W. Reindollar; P. D. Yin; U. Diva; R. Hindes; F. Mcphee; D. Hernandez; M. Wind-rotolo; E. A. Hughes; S. Schnittman

Book ID: 121812025
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 205 KB
Volume: 12
Category: Article
ISSN: 1473-3099
DOI: 10.1016/S1473-3099(12)70138-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral combination therapy with a nucleosi

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

✍ Edward J Gane; Stuart K Roberts; Catherine AM Stedman; Peter W Angus; Brett Ritc 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 316 KB

Simeprevir with pegylated interferon alf

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

✍ Jacobson, Ira M; Dore, Gregory J; Foster, Graham R; Fried, Michael W; Radu, Moni 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 284 KB

Simeprevir with pegylated interferon alf

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

✍ Manns, Michael; Marcellin, Patrick; Poordad, Fred; de Araujo, Evaldo Stanislau A 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 287 KB

Boceprevir versus placebo with pegylated

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial

✍ Sulkowski, Mark; Pol, Stanislas; Mallolas, Josep; Fainboim, Hugo; Cooper, Curtis 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 333 KB

1416 FALDAPREVIR PLUS PEGYLATED INTERFER

1416 FALDAPREVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONIC HCV GENOTYPE-1 TREATMENT-NAÏVE PATIENTS: FINAL RESULTS FROM STARTVERSO1, A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III TRIAL

✍ Ferenci, P.; Asselah, T.; Foster, G.R.; Zeuzem, S.; Sarrazin, C.; Moreno, C.; Ou 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection

✍ Peter Ferenci; Elisabeth Formann; Hermann Laferl; Michael Gschwantler; Franz Hac 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 182 KB